Featured Posts
Wall Street Journal
A Thumb on the Scale for Wegovy
The Biden administration announced one more bit of executive overreach on its way out the door. On Nov. 26, the Centers for Medicare and Medicaid…
Study
Evaluating Telehealth
Executive Summary Why Did We Write This Report Telehealth—the use of remote audio and/or video technologies to provide health care services—has been promoted as…
News Release
Report: Telehealth flexibility deadline looms, but Congress needs better information to decide
Congress is poised to consider proposals that permanently or temporarily extend flexibilities for telehealth services enacted during the COVID-19 pandemic that are set to expire…
Search Posts
National Review
Confronting Omicron: One Step Forward, One Step Static
President Joe Biden’s recent address on the Omicron variant was full of holiday miracles. After nearly a year in office, Biden finally conceded the…
The Wall Street Journal
Drug Prices Haven’t Been Going Up
Build Back Better may be dead, but its proposed drug price controls will likely reappear: negotiating prices for high-cost drugs in Medicare and price controls…
City Journal
Testing Our Patience
It has only been around a little more than a month, but the Omicron variant of the SARS-CoV-2 virus that causes Covid-19 has taken over.
National Review
Covid-19 Treatments and the FDA: A Sense of Urgency Might Help
As the Delta variant surges in various locales and the new Omicron variant expands around the globe, public officials are beginning to reimpose Covid-19…
National Review
The Covid Mandates Should Be Ignored
the highways in South Florida, the speed limit is generally 55 mph. I don’t know why, but it doesn’t matter: Everyone blows right through going…
Letters
CEI Joins NTU-Led Coalition Warns of BBB’s Impact on Drug Competition
Dear Senators and Representatives: On behalf of the undersigned organizations — taxpayer, consumer, and free market advocates from across the country — we write with…